Redox Ltd (ASX:RDX)
A$ 3.47 +0.18 (+5.47%) Market Cap: 1.82 Bil Enterprise Value: 1.74 Bil PE Ratio: 19.83 PB Ratio: 3.24 GF Score: 80/100

Full Year 2026 Redox Ltd Earnings Call Transcript

Aug 19, 2026 / 01:00 AM GMT
Release Date Price: A$3.59 (-5.53%)

Key Points

Positve
  • Redox Ltd (ASX:RDX) achieved record sales revenue of $1.33 billion, up 6.9%, driven by organic growth and strong performance in North America.
  • Gross profit increased 11% to $298 million, with the gross profit margin improving by 0.8 percentage points to 22.4%, reflecting a better product mix and resilient branding model.
  • North American revenue surged 33.8% to exceed $100 million for the first time, supported by new customer wins, expanded product range, and a coast-to-coast presence.
  • Statutory NPAT rose 19.2% to $92 million, with pro forma basic EPS up 19.2% to $0.175, and after-tax ROIC improved by 1.1 percentage points to 14.6%.
  • The company maintains a strong balance sheet with zero net debt, $123 million in cash, and improved free cash flow conversion to 62.5%, within its long-term target range.
  • Management expects price inflation from Middle East supply disruptions to provide tailwinds into FY27, with potential for 10-15% price increases based on historical precedents.
Negative
  • New Zealand sales declined 4% due to softer demand in the Human Health segment, impacted by a major customer losing a large contract.
  • Underlying operating expenses increased by $19 million to $176 million, driven by higher activity levels, wage growth, and increased investment in capabilities.
  • Geopolitical volatility, particularly the Middle East conflict, caused supply chain disruptions and product availability issues, creating uncertainty in demand and pricing.
  • The company faced a $4 million adverse movement in foreign exchange outcomes on receipts, partially offset by cost-winding movements on payments.
  • Management noted that while price inflation is expected, it could push down demand in some industries, and the exact magnitude and duration of price increases remain uncertain.
  • No acquisitions were completed in FY26, and management acknowledged that M&A opportunities in the US have been slower than hoped, with timing unpredictable.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RDX.AX - Redox Limited
Full Year 2026 Redox Ltd Earnings Call
Aug 20, 2026 / 01:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by and welcome to the Redox Limited full year 2026 results briefing.

All participants are in a listen-only mode.

There will be a presentation followed by a question-and-answer session.

If you wish to ask a question via the phones, you will need to press the star key followed by the number one on your telephone keypad.

If you wish to ask a question via webcast, please enter it into the ask a question box and click submit. I'd now like to hand the conference over to Mr. Raymond Conegliano with CEO. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot